Market Research Logo

US Market Report for Therapeutic Obstructive Sleep Apnea Devices 2017 - MedCore

US Market Report for Therapeutic Obstructive Sleep Apnea Devices 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
The market for sleep apnea therapy products has been growing over the years as diagnosis is becoming more prevalent. Patients are becoming more aware of this condition as apparent by the increasing number of PAP initiation and management procedures being conducted at hospitals.

This market has consistently been known to be limited by inefficiencies and patient discomfort for the devices required. Consequently, technology has been ever evolving and market segment growth continues to shift from one technology form to another. Similar to the oxygen therapy market, the market for sleep apnea devices is restricted by the Competitive Bidding Program, with consistent ASP declines as manufacturers push lower priced item products to win contracts for the Medicare program.

Over 50% of sleep apnea patients are covered by Medicare. With the aging population, this segment is set to drive growth of this market overall. Included in the sleep apnea market are the various positive airway pressure (PAP) devices as well as the market for the corresponding PAP masks which are used alongside the device. The market for PAP devices includes continuous positive airway pressure (CPAP) devices, auto-titrating positive airway pressure (APAP) devices, and bi-level positive airway pressure (BiPAP) devices. These devices are categorized collectively as sleep therapy interfaces and correspond to the following PAP device masks: nasal pillow masks, full face masks and nasal masks. The market for sleep therapy devices is nearly double in size of the PAP device market as these consumables require replacement multiple times per year.

In general, almost all patients diagnosed with sleep apnea are covered by some sort of insurance policy. Most of sleep therapy products, i.e. devices and related masks are included in these plans

Overall, the market for sleep therapy interfaces (masks) is set to grow at a faster rate than the positive airway market at a CAGR of 10.4%. Specifically driving growth in that market is the full-face and nasal pillow options are they offer greater patient comfort and have grown quite drastically in recent years. On the other hand, within the PAP device market, there has been a significant shift in markets away from CPAP devices towards APAP versions.

Obstructive sleep apnea is a respiratory disorder wherein an individual’s airway is obstructed during sleep as muscles relax and the airway walls and tissue collapse. The resulting asphyxia arouses the individual from the deeper stages of sleep so that normal breathing can be restored. It is this disruption of regular sleep rhythms that causes the negative symptoms associated with sleep apnea. During these events (termed “apneic events”), breathing ceases long enough to allow several normal breaths to be missed. In order to be considered an apneic event, a ten second interval between breaths and neurological arousal and/or blood oxygen desaturation are required. In most cases, the sufferer is unaware of experiencing such an event at the time, often simply falling back asleep afterwards.


EXECUTIVE SUMMARY
U.S. ANESTHESIA, RESPIRATORY AND SLEEP MANAGEMENT MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PRODUCT ASSESSMENT
2.1 PRODUCT PORTFOLIOS
2.1.1 Therapeutic Obstructive Sleep Apnea
2.2 REGULATORY ISSUES AND RECALLS
2.2.1 BD-Carefusion
2.2.1.1 Anesthesia Disposables Devices
2.2.1.2 Ventilator Devices
2.2.1.3 Respiratory Disposables
2.2.2 Draeger
2.2.2.1 Anesthesia Delivery
2.2.2.2 Ventilator Devices
2.2.2.3 Anesthesia Disposables
2.2.3 Drive-DeVilbiss
2.2.3.1 Therapeutic Obstructive Sleep Apnea
2.2.4 GE Healthcare
2.2.4.1 Anesthesia Delivery Unit
2.2.4.2 Anesthesia Monitor
2.2.5 Invacare
2.2.5.1 Oxygen Therapy
2.2.6 Natus-Embla
2.2.6.1 Sleep Diagnostics
2.2.7 Philips Healthcare
2.2.7.1 Anesthesia Monitor
2.2.8 ResMed
2.2.8.1 Ventilators
2.2.9 Teleflex
2.2.9.1 Respiratory Disposables
2.3 CLINICAL TRIALS
2.3.1 Drive-DeVilbiss
2.3.1.1 CPAP Devices
2.3.2 Fisher & Paykel
2.3.2.1 Therapeutic Obstructive Sleep Apnea Devices
2.3.3 GE Healthcare
2.3.3.1 Anesthesia Information Management System
2.3.4 ResMed
2.3.4.1 Ventilators
2.3.4.2 Therapeutic Obstructive Sleep Apnea Devices
2.3.4.3 Sleep Diagnostic Devices
2.3.5 Teleflex
2.3.5.1 Oxygen Therapy
THERAPEUTIC OBSTRUCTIVE SLEEP APNEA DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Positive Airway Pressure (PAP) Device Market
3.3.1.1 Continuous Positive Airway Pressure (CPAP) Device Market
3.3.1.2 Auto-Titrating Positive Airway Pressure (APAP) Device Market
3.3.1.3 Bi-Level Positive Airway Pressure Device Market
3.3.2 Total Sleep Therapy Interface Market
3.3.2.1 Nasal Mask Market
3.3.2.2 Full-Face Mask Market
3.3.2.3 Nasal Pillow/Alternative Interface Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Anesthesia, Respiratory and Sleep Management Market by Segment, U.S., 2013 – 2023
Chart 1 2: Anesthesia, Respiratory and Sleep Management Overview, U.S., 2016 & 2023
Chart 3 1: Therapeutic Obstructive Sleep Apnea Device Market by Segment, U.S., 2013 – 2023
Chart 3 2: Therapeutic Obstructive Sleep Apnea Device Market Breakdown, U.S., 2016
Chart 3 3: Therapeutic Obstructive Sleep Apnea Device Market Breakdown, U.S., 2023
Chart 3 4: Total Positive Airway Pressure (PAP) Device Market, U.S., 2013 – 2023
Chart 3 5: Continuous Positive Airway Pressure (CPAP) Device Market, U.S., 2013 – 2023
Chart 3 6: Auto-Titrating Positive Airway Pressure (APAP) Device Market, U.S., 2013 – 2023
Chart 3 7: Bi-Level Positive Airway Pressure Device Market, U.S., 2013 – 2023
Chart 3 8: Total Sleep Therapy Interface Market, U.S., 2013 – 2023
Chart 3 9: Nasal Mask Market, U.S., 2013 – 2023
Chart 3 10: Full-Face Mask Market, U.S., 2013 – 2023
Chart 3 11: Nasal Pillow/Alternative Interface Market, U.S., 2013 – 2023
Chart 3 12: Leading Competitors, Positive Airway Pressure Device Market, U.S., 2016
List of Figures
Figure 1 1: Anesthesia, Respiratory and Sleep Management Competitor Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Anesthesia, Respiratory and Sleep Management Competitor Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Anesthesia, Respiratory and Sleep Management Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Anesthesia, Respiratory and Sleep Management Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Anesthesia, Respiratory and Sleep Management Market, U.S., 2013 – 2016
Figure 1 7: Procedure Codes Investigated, U.S., 2016
Figure 1 8: Anesthesia, Respiratory and Sleep Management Markets Covered, U.S., 2016 (1 of 4)
Figure 1 9: Anesthesia, Respiratory and Sleep Management Markets Covered, U.S., 2016 (2 of 4)
Figure 1 10: Anesthesia, Respiratory and Sleep Management Markets Covered, U.S., 2016 (3 of 4)
Figure 1 11: Anesthesia, Respiratory and Sleep Management Markets Covered, U.S., 2016 (4 of 4)
Figure 1 12: Key Report Updates
Figure 1 13: Version History
Figure 2 1: Therapeutic Obstructive Sleep Apnea Devices by Company (2 or 3)
Figure 2 2: Therapeutic Obstructive Sleep Apnea Devices by Company (3 or 3)
Figure 2 3: Class 2 Device Recall BD-Carefusion
Figure 2 4: Class 2 Device Recall BD-Carefusion
Figure 2 5: Class 2 Device Recall BD-CareFusion
Figure 2 6: Class 1 Device Recall BD-CareFusion
Figure 2 7: Class 1 Device RecallBD-CareFusion
Figure 2 8: Class 1 Device Recall BD-CareFusion
Figure 2 9: Class 1 Device Recall BD-CareFusion
Figure 2 10: Class 2 Device Recall BD-CareFusion
Figure 2 11: Class 2 Device Recall Draeger
Figure 2 12: Class 1 Device Recall Draeger
Figure 2 13: Class 2 Device Recall Draeger
Figure 2 14: Class 2 Device Recall Draeger
Figure 2 15: Class 1 Device Recall Draeger
Figure 2 16: Class 1 Device Recall Draeger
Figure 2 17: Class 1 Device Recall Draeger
Figure 2 18: Class 1 Device Recall Draeger
Figure 2 19: Class 2 Device Recall Draeger
Figure 2 20: Class 2 Device Recall Draeger
Figure 2 21: Class 2 Device Recall Draeger
Figure 2 22: Class 3 Device Recall DeVilbiss
Figure 2 23: Class 2 Device Recall GE Healthcare
Figure 2 24: Class 2 Device Recall GE Healthcare
Figure 2 25: Class 2 Device Recall GE Healthcare
Figure 2 26: Class 2 Device Recall GE Healthcare
Figure 2 27: Class 2 Device Recall GE Healthcare
Figure 2 28: Class 2 Device Recall GE Healthcare
Figure 2 29: Class 2 Device Recall GE Healthcare
Figure 2 30: Class 2 Device Recall GE Healthcare
Figure 2 31: Class 2 Device Recall GE Healthcare
Figure 2 32: Class 2 Device Recall GE Healthcare
Figure 2 33: Class 2 Device Recall GE Healthcare
Figure 2 34: Class 2 Device Recall GE Healthcare
Figure 2 35: Class 2 Device Recall GE Healthcare
Figure 2 36: Class 2 Device Recall GE Healthcare
Figure 2 37: Class 2 Device Recall GE Healthcare
Figure 2 38: Class 2 Device Recall GE Healthcare
Figure 2 39: Class 2 Device Recall GE Healthcare
Figure 2 40: Class 2 Device Recall Invacare
Figure 2 41: Class 2 Device Recall Invacare
Figure 2 42: Class 2 Device Recall Natus-Embla
Figure 2 43: Class 2 Device Recall Philips Healthcare
Figure 2 44: Class 2 Device Recall ResMed
Figure 2 45: Class 2 Device Recall ResMed
Figure 2 46: Class 1 Device Recall Teleflex
Figure 2 47: Class 1 Device Recall Teleflex
Figure 2 48: Class 2 Device Recall Teleflex
Figure 2 49: Revised Algorithm for Next Generation DeVilbiss Healthcare CPAP
Figure 2 50: Laboratory Assessment of Pilairo Q CPAP Mask Performance and Ease of Use
Figure 2 51: CPAP In-home Assessment NZ
Figure 2 52: CPAP In-home Assessment Australia
Figure 2 53: CPAP In-home Assessment Australia
Figure 2 54: Investigative Headgear With CPAP Mask
Figure 2 55: Evaluation of APAP With SensAwake in OSA and Insomnia Patients
Figure 2 56: Pilairo Lab Market Research
Figure 2 57: A Comparison of CPAP With and Without Humidification: A Pilot Study
Figure 2 58: Comparison Study of the ICON™ CPAP Series With and Without SensAwake™
Figure 2 59: Airway Pressure During Nasal High Flow and CPAP in Neonates
Figure 2 60: Airway Pressure During Nasal High Flow and CPAP in Neonates
Figure 2 61: The Evaluation of a Gender-based Sizing Model for Full Face Masks
Figure 2 62: Measurement of NonInvasive Blood Pressure
Figure 2 63: Intelligent Volume Assured Pressure Support to Improve Sleep Quality and Respiratory Events
Figure 2 64: Adaptive Servo Ventilation (ASV) in Heart Failure
Figure 2 65: Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients
Figure 2 66: AutoSet for Her Quality of Life Clinical Trial (FEM-PAP)
Figure 2 67: CPAP vs ASV for Insomnia (P2P)
Figure 2 68: Comparison of Auto-Adjusting Positive Airway Pressure Devices
Figure 2 69: Pilot Study Evaluating Feasibility and Benefits of Telemonitored NIV Treatment
Figure 2 70: Positive Airway Pressure Therapy Study in Sleep Apnea
Figure 2 71: The Evaluation of a New Sleep Algorithm
Figure 2 72: Efficacy of Telemonitoring on CPAP Treatment
Figure 2 73: Evaluation and Control of WAG in PACU Within Patient and Caregiver Breathing Zone
Figure 3 1: Therapeutic Obstructive Sleep Apnea Device Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 3 2: Total Positive Airway Pressure (PAP) Device Market, U.S., 2013 – 2023
Figure 3 3: Continuous Positive Airway Pressure (CPAP) Device Market, U.S., 2013 – 2023
Figure 3 4: Auto-Titrating Positive Airway Pressure (APAP) Device Market, U.S., 2013 – 2023
Figure 3 5: Bi-Level Positive Airway Pressure Device Market, U.S., 2013 – 2023
Figure 3 6: Total Sleep Therapy Interface Market, U.S., 2013 – 2023
Figure 3 7: Nasal Mask Market, U.S., 2013 – 2023
Figure 3 8: Full-Face Mask Market, U.S., 2013 – 2023
Figure 3 9: Nasal Pillow/Alternative Interface Market, U.S., 2013 – 2023
Figure 3 10: Drivers and Limiters, Therapeutic Obstructive Sleep Apnea Device Market U.S., 2016
Figure 3 11: Leading Competitors, Sleep Apnea Device/Interface Market, U.S., 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report